Reading Seminars on Health Innovation
Previous seminars
- December 10, 2018
- Scientific, regulatory, and economic challenges facing the implementation of phage therapy and the Belgian model.
Bob Blasdel Research Director for Vesale Pharma
- November 30, 2018
- The case of a multi-drug resistant infection
- November 26, 2018
- Precision oncology: how to structure the continuum of clinical research into healthcare for rationale access to anti-cancer treatment
Denis Lacombe Director General of the European Organisation for Research and Treatment of Cancer
- November 12, 2018
- Market definition in the pharmaceutical industry: a case of drugs hopping antitrust markets
Georges Siotis Associate Professor at the Economics Department of Universidad Carlos III de Madrid and CEPR Research Fellow
- October 29, 2018
- Towards new partnerships in the healthcare sector
Wim Van Haverbeke Professor of Innovation Management & Strategy at the Hasselt University
- October 08, 2018
- Vaccines: how to value them, how to price them?
Michel Dewilde MDWConsultant, former Senior Vice President R&D, Sanofi Pasteur
- October 01, 2018
- Measuring mortality in conflicts and disasters: why does it matter?
Debarati Guha Director of the Centre for Research on the Epidemiology of Disasters (CRED) and Professor at the School of Public Health (UCL)
- June 04, 2018
- Public funding and influential health research: Evidence from the US and the UK
Charitini Stavropoulou Senior Lecturer in Health Management at the School of Health Sciences (City University of London)
- May 28, 2018
- Endogenous childlessness and stages of development
Paula E. Gobbi Member of ECARES (ULB) and CEPR
- May 07, 2018
- Translational hepatology: scientific, economic and financial challenges
Etienne Sokal Professor at UCLouvain, Hepatologist at Cliniques Universitaires Saint Luc and Founder of Promethera Biosciences
